BIO Welcomes New Executive Committee and Section Governing Board Members
Washington, D.C. (June 19, 2012) – The Board of Directors of the Biotechnology Industry Organization (BIO) elected its Executive Committee and added new members to Section Governing Boards in a meeting held in conjunction with the 2012 BIO International Convention, the global event for biotechnology, taking place June 18-21, 2012 at the Boston Convention and Exhibition Center in Boston, MA.
“We are pleased to welcome the new members of the Executive Committee and Section Governing Boards,” stated BIO President and CEO Jim Greenwood. “Their new perspectives and ideas are valuable additions to the collective expertise of the BIO Board as we advocate for public policy in the U.S. and around the world that encourages the research and development necessary for continued innovation in breakthrough medical therapies, enhanced agricultural products and revolutionary biofuels.”
H. Thomas Watkins, President and CEO of Human Genome Sciences, Inc., will continue to serve as the Chair of the Board of Directors and of the Health Section Governing Board.
Members of the Executive Committee of BIO’s Board of Directors for the 2012-2013 term are:
·Fabrizio Bonanni, Board Secretary
Executive Vice President, Operations, Amgen, Inc.
·Ian Clark, At Large
CEO & Head of North American Commercial Operations, Genentech, Roche Group
·Ron Cohen, At Large
President & CEO, Acorda Therapeutics, Inc.
·Deborah Dunsire, At Large
President & CEO, Millennium: The Takeda Oncology Company
·Geno Germano, At Large
President and General Manager of Specialty Care and Oncology, Pfizer, Inc.
·Peter Greenleaf, At Large
President, MedImmune, AstraZeneca, PLC
·Paul Hastings, Emerging Companies Section Chair
President & CEO, OncoMed Pharmaceuticals, Inc.
·Rachel King, Health Section Vice Chair
President & CEO, GlycoMimetics, Inc.
·John Maraganore, Emerging Companies Section Vice Chair
Chief Executive Officer, Alnylam Pharmaceuticals, Inc.
·Adam Monroe, Industrial & Environmental Section Chair
President, Novozymes North America, Novozymes
·Richard Pops, At Large
Chairman & CEO, Alkermes, plc
·David Pyott, At Large
Chairman & CEO, Allergan, Inc.
·Stephen Sherwin, Board Immediate Past Chair
Chair Emeritus
·Jay Siegel, At Large
Chief Biotechnology Officer & Head, Global Regulatory Affairs, Johnson and Johnson
·Mark Skaletsky, Board Treasurer
Chairman & CEO, Fenway Pharmaceuticals, Inc.
·Gerald Steiner, Food & Agriculture Section Vice Chair
Executive Vice President, Sustainability & Corporate Affairs, Monsanto Company
·Steve Tuttle, Industrial & Environmental Section Vice Chair
Global Business Director Biosciences Ventures & Business Development, The Dow Chemical Company
·H. Thomas Watkins, Board & Health Section Chair
President & CEO, Human Genome Sciences, Inc.
·Barbara Wells, Food & Agriculture Section Chair
President, BHW Enterprises, LLC, ArborGen, Inc.
The full BIO Board of Directors is comprised of the elected Directors serving on each of BIO’s Section Governing Boards (Emerging Companies, Food and Agriculture, Health, and Industrial and Environmental). The newly-elected Board Members from these sections are:
Emerging Companies Section Governing Board
·Arlene Morris, Chief Executive Officer, Syndax Pharmaceuticals, Inc.
·Mike Naraci, Chief Executive Officer, Orexigen Therapeutics, Inc.
·David Schenkein, Chief Executive Officer, Agios Pharmaceuticals, Inc.
·Moncef Slaoui, Chairman, Research & Development, GlaxoSmithKline, plc
Food and Agriculture Section Governing Board
No New Members
Health Section Governing Board
·Marc Beer, Chief Executive Officer, Aegerion Pharmaceuticals, Inc.
·Jeff Leiden, President & CEO, Vertex Pharmaceuticals Incorporated
·Nick Leschly, President & CEO, bluebird bio
·Kenneth Moch, President & CEO, Chimerix, Inc.
·John Orwin, Chief Executive Officer, Affymax, Inc.
·Moncef Slaoui, Chairman, Research & Development, GlaxoSmithKline, plc
·Henri Termeer, Chair Emeritus
Industrial and Environmental Section Governing Board
·Jill Zullo, Technical Director, Cargill, Inc.
·James Collins, President, DuPont Industrial Biosciences
·John Nicols, President & CEO, Codexis, Inc.
A full list of the members of the Section Governing Boards can be found at http://www.bio.org/node/3843.